VANCOUVER, British Columbia, May 14, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has closed a non-brokered private placement (the “Offering”) with one strategic investor by issuing 1,142,857 common shares at a price of USD$0.70 per common share for gross proceeds of USD$800,000.


Previous articlePTSF59 – Bipolar and Psychedelics, with Benjamin Mudge
Next articleMindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial